Hudson Bay Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-227,500	Closed	-$3.38M	–	1647
2025 Q1	$3.38M	Sell	227,500 -47,500	-17%	-$666K	0.01%	697
2024 Q4	$3.64M	Buy	275,000 +25,000	+10%	+$343K	0.01%	559
2024 Q3	$3.56M	Sell	250,000 -100,000	-29%	-$1.42M	0.01%	490
2024 Q2	$4.53M	Buy	350,000 +175,000	+100%	+$2.32M	0.02%	396
2024 Q1	$2.43M	Hold	175,000	–	–	0.01%	425
2023 Q4	$2.5M	Buy	+175,000	New	+$2.48M	0.02%	412
2022 Q4	–	Sell	-130,000	Closed	-$1.69M	–	1107
2022 Q3	$1.69M	Buy	130,000 +10,000	+8%	+$139K	0.01%	771
2022 Q2	$1.69M	Sell	120,000 -95,000	-44%	-$1.36M	0.01%	839
2022 Q1	$3.08M	Sell	215,000 -50,000	-19%	-$734K	0.04%	560
2021 Q4	$3.61M	Buy	265,000 +80,000	+43%	+$1.12M	0.04%	483
2021 Q3	$3.03M	Buy	185,000 +10,000	+6%	+$168K	0.04%	519
2021 Q2	$2.94M	Buy	+175,000	New	+$2.98M	0.04%	522
2020 Q1	–	Sell	-548,068	Closed	-$10.8M	–	575
2019 Q4	$10.8M	Sell	548,068 -601,693	-52%	-$11.5M	0.24%	74
2019 Q3	$19.8M	Buy	1,149,761 +87,231	+8%	+$1.51M	0.55%	36
2019 Q2	$18.8M	Buy	1,062,530 +432,192	+69%	+$7.86M	0.43%	41
2019 Q1	$12.8M	Buy	630,338 +614,590	+3,903%	+$12.4M	0.17%	120
2018 Q4	$265K	Buy	+15,748	New	+$266K	﹤0.01%	724